PL3544420T3 - Zastosowanie kompozycji do konserwowania narządów/tkanek - Google Patents
Zastosowanie kompozycji do konserwowania narządów/tkanekInfo
- Publication number
- PL3544420T3 PL3544420T3 PL17829007.8T PL17829007T PL3544420T3 PL 3544420 T3 PL3544420 T3 PL 3544420T3 PL 17829007 T PL17829007 T PL 17829007T PL 3544420 T3 PL3544420 T3 PL 3544420T3
- Authority
- PL
- Poland
- Prior art keywords
- organ
- compositions
- tissue preservation
- preservation
- tissue
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 210000000056 organ Anatomy 0.000 title 1
- 238000004321 preservation Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/03—Monoamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Environmental Sciences (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP1600639 | 2016-11-24 | ||
| PCT/HU2017/050051 WO2018096376A1 (en) | 2016-11-24 | 2017-11-24 | Compositions for organ preservation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3544420T3 true PL3544420T3 (pl) | 2022-11-21 |
Family
ID=89720188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17829007.8T PL3544420T3 (pl) | 2016-11-24 | 2017-11-24 | Zastosowanie kompozycji do konserwowania narządów/tkanek |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20190335745A1 (pl) |
| EP (1) | EP3544420B8 (pl) |
| CN (1) | CN110337244B (pl) |
| CA (1) | CA3044746A1 (pl) |
| DK (1) | DK3544420T3 (pl) |
| ES (1) | ES2926179T3 (pl) |
| HU (1) | HUE060027T2 (pl) |
| IL (1) | IL266833B (pl) |
| MA (1) | MA46898A (pl) |
| PL (1) | PL3544420T3 (pl) |
| WO (1) | WO2018096376A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10918102B2 (en) | 2014-03-13 | 2021-02-16 | The General Hospital Corporation | Devices and methods to improve and assess viability of human livers |
| WO2022241417A1 (en) * | 2021-05-10 | 2022-11-17 | The General Hospital Corporation | Methods and compositions for extending organ and tissue preservation |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3692835A (en) | 1967-04-05 | 1972-09-19 | Jan Van Dijk | Pharmacologically active amino-ethyl oximes |
| NL7503310A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| NL7503312A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| NL7503309A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| US4083978A (en) | 1976-01-27 | 1978-04-11 | Egyt Gyogyszervegyeszeti Gyar | Oxime ethers |
| US5086054A (en) | 1990-07-31 | 1992-02-04 | Sri International | Novel arylcycloalkanepolyalkylamines |
| US6297212B1 (en) * | 1994-05-31 | 2001-10-02 | Gregory M. Fahy | Growth hormone therapy and related methods and pharmaceutical compositions |
| IN184685B (pl) * | 1996-02-14 | 2000-09-23 | Nat Inst Immunology | |
| IN186677B (pl) | 1999-11-12 | 2001-10-20 | Sun Pharmaceutical Ind Ltd | |
| US8765364B2 (en) * | 2007-05-18 | 2014-07-01 | Lifeline Scientific, Inc. | Ex vivo methods for validating substance testing with human organs and/or tissues |
| JP5188583B2 (ja) * | 2008-01-04 | 2013-04-24 | エルジー・ライフ・サイエンシーズ・リミテッド | 細胞、組織及び臓器保存効果を有するインドール及びインダゾール誘導体 |
| SE533552C2 (sv) * | 2008-12-30 | 2010-10-26 | Igeloesa Transplantation Science Ab | Förfarande och lösning för behandling av en potentiell organdonator |
| AU2010269111B2 (en) * | 2009-07-09 | 2014-12-11 | Ozteo Pty Ltd | Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers |
| EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
| WO2011123695A1 (en) * | 2010-03-31 | 2011-10-06 | Abela Pharmaceuticals, Inc. | Dimethy sulfoxxide (dmso) formulations for treating autism |
| SE534862C2 (sv) * | 2010-05-14 | 2012-01-24 | Vivoline Medical Ab | Användning av en medicinsk vätska för behandling av ett uttaget organ |
| ES2539972T3 (es) * | 2010-07-30 | 2015-07-07 | Nerviano Medical Sciences S.R.L. | Isoxazolo-quinazolinas como moduladores de la actividad de proteina cinasa |
| AU2012319223B2 (en) * | 2011-10-03 | 2016-08-18 | Vivoline Medical Ab | Medical fluid comprising globulin and its use for preservation of harvested organs |
| HUE053165T2 (hu) * | 2014-02-07 | 2021-06-28 | Tamogatott Kutatocsoportok Irodaja | Szigma-1-receptor-agonista vegyületek új alkalmazása |
| CN104292126B (zh) * | 2014-08-14 | 2016-08-24 | 广东东阳光药业有限公司 | 萘衍生物及其在药物上的应用 |
| US20170295776A1 (en) * | 2016-04-18 | 2017-10-19 | University Of Cincinnati | Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells |
-
2017
- 2017-11-24 CA CA3044746A patent/CA3044746A1/en active Pending
- 2017-11-24 PL PL17829007.8T patent/PL3544420T3/pl unknown
- 2017-11-24 WO PCT/HU2017/050051 patent/WO2018096376A1/en unknown
- 2017-11-24 HU HUE17829007A patent/HUE060027T2/hu unknown
- 2017-11-24 CN CN201780084580.9A patent/CN110337244B/zh active Active
- 2017-11-24 ES ES17829007T patent/ES2926179T3/es active Active
- 2017-11-24 DK DK17829007.8T patent/DK3544420T3/da active
- 2017-11-24 US US16/463,944 patent/US20190335745A1/en active Pending
- 2017-11-24 EP EP17829007.8A patent/EP3544420B8/en active Active
- 2017-11-24 MA MA046898A patent/MA46898A/fr unknown
-
2019
- 2019-05-23 IL IL266833A patent/IL266833B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN110337244B (zh) | 2023-07-21 |
| EP3544420A1 (en) | 2019-10-02 |
| US20190335745A1 (en) | 2019-11-07 |
| HUE060027T2 (hu) | 2023-01-28 |
| IL266833A (en) | 2019-08-29 |
| MA46898A (fr) | 2019-10-02 |
| CA3044746A1 (en) | 2018-05-31 |
| EP3544420B8 (en) | 2022-11-23 |
| CN110337244A (zh) | 2019-10-15 |
| IL266833B (en) | 2022-01-01 |
| ES2926179T3 (es) | 2022-10-24 |
| EP3544420B1 (en) | 2022-06-22 |
| DK3544420T3 (da) | 2022-09-05 |
| WO2018096376A1 (en) | 2018-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2600267B (en) | Measurement of tissue viability | |
| IL259123B (en) | The compositions for applying to the skin | |
| IL248160A0 (en) | Compositions of tissue fillers and methods of use | |
| EP3352771A4 (en) | OMBILICAL TISSUE COMPOSITIONS AND METHODS OF USE | |
| SG11201912185XA (en) | Three dimensional tissue compositions and methods of use | |
| IS050183A (en) | Method of tissue preservation | |
| IL275739A (en) | Preparations for cryopreservation and methods of their use | |
| EP3675632A4 (en) | METHODS AND COMPOSITIONS FOR PRESERVING TISSUE | |
| PL3302523T3 (pl) | Kompozycja do leczenia zmian tkankowych | |
| PT3297625T (pt) | Composto para a profilaxia ou tratamento de nefropatia diabética ou doença renal diabética | |
| IL272857A (en) | Cofanalisib formulations | |
| PL3544420T3 (pl) | Zastosowanie kompozycji do konserwowania narządów/tkanek | |
| IL256919A (en) | Pharmaceutical compositions useful for the treatment of tissue damage | |
| EP3377054A4 (en) | HOMOTAURINE ENRICHED COMPOSITION AND METHODS OF USE IN ANIMAL HEALTH | |
| PT3678644T (pt) | Formulações de copanlisib | |
| EP3445174A4 (en) | ROMARIN / PHOSPHOLIPASE COMPOSITIONS AND METHODS FOR THE PRESERVATION OF MUSCLE TISSUE | |
| SG11201706369PA (en) | Compositions and methods for the treatment of mucositis | |
| IL263514A (en) | Using lyso-gb1 as a drug target | |
| ZA201606358B (en) | Compositions of selenoorganic compounds and methods and methods of use thereof | |
| PT3128938T (pt) | Dispositivo bipolar para a ressecção cirúrgica de tecidos |